Amgen 2012 Annual Report Download - page 90

Download and view the complete annual report

Please find page 90 of the 2012 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 150

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150

83
Exhibit No. Description
4.13 Officers’ Certificate of Amgen Inc., dated as of May 23, 2008, including forms of the Company’s 6.15%
Senior Notes due 2018 and 6.90% Senior Notes due 2038. (Filed as exhibit to Form 8-K on May 23, 2009
and incorporated herein by reference.)
4.14 Officers’ Certificate of Amgen Inc., dated as of January 16, 2009, including forms of the Company’ s 5.70%
Senior Notes due 2019 and 6.40% Senior Notes due 2039. (Filed as exhibit to Form 8-K on January 16,
2009 and incorporated herein by reference.)
4.15 Officers’ Certificate of Amgen Inc., dated as of March 12, 2010, including forms of the Company’ s 4.50%
Senior Notes due 2020 and 5.75% Senior Notes due 2040. (Filed as exhibit to Form 8-K on March 15,
2010 and incorporated herein by reference.)
4.16 Officers’ Certificate of Amgen Inc., dated as of September 16, 2010, including forms of the Company’ s
3.45% Senior Notes due 2020 and 4.95% Senior Notes due 2041. (Filed as an exhibit to Form 8-K on
September 17, 2010 and incorporated herein by reference.)
4.17 Officers’ Certificate of Amgen Inc., dated as of June 30, 2011, including forms of the Company’ s 2.30%
Senior Notes due 2016, 4.10% Senior Notes due 2021 and 5.65% Senior Notes due 2042. (Filed as an
exhibit to Form 8-K on June 30, 2011 and incorporated herein by reference.)
4.18 Officers’ Certificate of Amgen Inc., dated as of November 10, 2011, including forms of the Company’ s
1.875% Senior Notes due 2014, 2.50% Senior Notes due 2016, 3.875% Senior Notes due 2021 and 5.15%
Senior Notes due 2041. (Filed as an exhibit to Form 8-K on November 10, 2011 and incorporated herein
by reference.)
4.19 Officers’ Certificate of Amgen Inc., dated as of December 5, 2011, including forms of the Company’ s
4.375% Senior Notes due 2018 and 5.50% Senior Notes due 2026. (Filed as an exhibit to Form 8-K on
December 5, 2011 and incorporated herein by reference.)
4.20 Officers' Certificate of Amgen Inc., dated as of May 15, 2012, including forms of the Company's
2.125% Senior Notes due 2017, 3.625% Senior Notes due 2022 and 5.375% Senior Notes due 2043.
(Filed as an exhibit to Form 8-K on May 15, 2012 and incorporated herein by reference.)
4.21 Officers' Certificate of Amgen Inc., dated as of September 13, 2012, including forms of the Company's
2.125% Senior Notes due 2019 and 4.000% Senior Notes due 2029. (Filed as an exhibit to Form 8-K on
September 13, 2012 and incorporated herein by reference.)
10.1+ Amgen Inc. 2009 Equity Incentive Plan. (Filed as Appendix A to the Definitive Proxy Statement on Schedule
14A on March 26, 2009 and incorporated herein by reference.)
10.2+ Form of Stock Option Agreement for the Amgen Inc. 2009 Equity Incentive Plan. (As Amended on
October 10, 2012.) (Filed as an exhibit to Form 10-Q for the quarter ended September 30, 2012 on
November 6, 2012 and incorporated herein by reference.)
10.3+ Form of Restricted Stock Unit Agreement for the Amgen Inc. 2009 Equity Incentive Plan. (As Amended
on October 10, 2012.) (Filed as an exhibit to Form 10-Q for the quarter ended September 30, 2012 on
November 6, 2012 and incorporated herein by reference.)
10.4+* Amgen Inc. 2009 Performance Award Program. (As Amended on December 13, 2012.)
10.5+ Form of Performance Unit Agreement for the Amgen Inc. 2009 Performance Award Program. (As
Amended on March 14, 2012.) (Filed as an exhibit to Form 10-Q for the quarter ended March 31, 2012
on May 8, 2012 and incorporated herein by reference.)
10.6+* Amgen Inc. 2009 Director Equity Incentive Program. (As Amended and Restated on December 13, 2012.)
10.7+ Form of Grant of Non-Qualified Stock Option Agreement for the Amgen Inc. 2009 Director Equity Incentive
Program. (Filed as an exhibit to Form 8-K on May 8, 2009 and incorporated herein by reference.)
10.8+* Form of Restricted Stock Unit Agreement for the Amgen Inc. 2009 Director Equity Incentive Program.
(As Amended and Restated on December 13, 2012.)